The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, M. | - |
dc.contributor.author | Choi, M. | - |
dc.date.accessioned | 2021-09-05T00:00:58Z | - |
dc.date.available | 2021-09-05T00:00:58Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 2210-9099 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/95953 | - |
dc.description.abstract | Objectives: This study analyzes the influence of the financial structure of pharmaceutical companies on R&D investment to create a next-generation profit source or develop relatively cost-effective drugs to maximize enterprise value. Methods: The period of the empirical analysis is from 2000 to 2012. Financial statements and comments in general and internal transactions were extracted from TS-2000 of the Korea Listed Company Association (KLCA), and data related to stock price is extracted from KISVALUE-III of NICE Information Service Co., Ltd. Stata 12.0 was used as the statistical package for panel analysis. Results: The current ratio had a positive influence on R&D investment, the debt ratio had a negative influence on R&D investment, and return on investment and net sales growth rate did not have a significant influence on R&D investment. Conclusion: It was found in this study that the higher liquidity ratio, the greater the R&D investment. The stability of pharmaceutical companies has a negative influence on R&D investment. This finding is consistent with the prediction that if a company faces a financial risk, it will be passive in R&D investment due to its financial difficulties. © 2015 Korea Centers for Disease Control and Prevention. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | Elsevier B.V. | - |
dc.subject | Article | - |
dc.subject | drug cost | - |
dc.subject | drug industry | - |
dc.subject | drug research | - |
dc.subject | financial deficit | - |
dc.subject | financial management | - |
dc.subject | investment | - |
dc.subject | priority journal | - |
dc.subject | product development | - |
dc.subject | profit | - |
dc.title | The Determinants of Research and Development Investment in the Pharmaceutical Industry: Focus on Financial Structures | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, M. | - |
dc.contributor.affiliatedAuthor | Choi, M. | - |
dc.identifier.doi | 10.1016/j.phrp.2015.10.013 | - |
dc.identifier.scopusid | 2-s2.0-84949625280 | - |
dc.identifier.bibliographicCitation | Osong Public Health and Research Perspectives, v.6, no.5, pp.302 - 309 | - |
dc.relation.isPartOf | Osong Public Health and Research Perspectives | - |
dc.citation.title | Osong Public Health and Research Perspectives | - |
dc.citation.volume | 6 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 302 | - |
dc.citation.endPage | 309 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002241482 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | Article | - |
dc.subject.keywordPlus | drug cost | - |
dc.subject.keywordPlus | drug industry | - |
dc.subject.keywordPlus | drug research | - |
dc.subject.keywordPlus | financial deficit | - |
dc.subject.keywordPlus | financial management | - |
dc.subject.keywordPlus | investment | - |
dc.subject.keywordPlus | priority journal | - |
dc.subject.keywordPlus | product development | - |
dc.subject.keywordPlus | profit | - |
dc.subject.keywordAuthor | Financial structure | - |
dc.subject.keywordAuthor | Panel study | - |
dc.subject.keywordAuthor | Pharmaceutical company | - |
dc.subject.keywordAuthor | Research and development investment | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.